antraciclinas

Cuidados de enfermagem relacionados à cardiotoxicidade envolvendo drogas como a antraciclinas e anticorpo monoclonais no tratamento oncológico

Resumo: Introduction: Cardiovascular diseases in cancer patients are increasingly frequent events, due to advances in cancer therapy that have resulted both in improving quality of life and increasing patient survival. In recent decades, progress in cancer treatment has also resulted in increased exposure of patients to cardiovascular risk factors and chemotherapy with potential for cardiotoxicity. Review: This is a work of bibliographic review of the integrative type, aimed at evaluating nursing care in the use of antineoplastic as main adverse effects to cardiotoxicity and reporting the severity of the use of anthracycline and monoclonal antibody. Discussion: Anthracyclines are antitumor antibiotics, widely used in various types of cancer and monoclonal antibodies is a type of immunological therapy and can be combined with conventional treatments, as it is also an antitumor. Both are a recognized cause of cardiotoxicity. Final considerations: It is of fundamental importance that nursing act before, during and after chemotherapy administration, observing the signs and symptoms and guiding both the patient and the family member about the antineoplastic used, its action on the body, its side effects and care in general. Keywords:cardiotoxicity, anthracyclines, monoclonal antibody, nursing care. Expandir Resumo Acessar Texto Completo